Health Risks of Herbal Remedies

Summary

Herbal remedies can result in indirect health risks when they delay or replace a more effective form of conventional treatment or when they compromise the efficacy of conventional medicines. Herbal remedies can also be associated with direct health risks. Long-standing traditional experience may tell much about striking and predictable symptoms of acute toxicity but it is a less reliable tool for the detection of reactions which are inconspicuous, develop gradually or have a prolonged latency period, or which occur uncommonly. Another reason why safety claims cannot always be based on traditional empiricism is that not all herbal remedies are firmly rooted in traditional medicine.

The risk of a herbal remedy producing an adverse reaction depends not only on the remedy and its dosage but also on consumer-related parameters, such as age, genetics, concomitant diseases and concurrent use of other drugs. Another important determinant of the toxicity of herbal remedies is their quality.

What is already known about the risks of herbal remedies must be systematically collected, disseminated and acted upon. What is yet unknown must be found out by herbal postmarketing surveillance and experimental research.

This is a preview of subscription content, access via your institution.

References

  1. 1.

    De Smet PAGM. Legislatory outlook on the safety of herbal remedies. In: De Smet PAGM, Hänsel R, Keller, et al., editors. Adverse effects of herbal drugs. Vol 2. Heidelberg: Springer-Verlag, 1993: 1–90

    Chapter  Google Scholar 

  2. 2.

    De Smet PAGM, Stricker BHCh, Nijman JJ. Indirecte risico’s van alternatieve middelen. Een oproep tot het rapporteren van concrete gevallen. Med Contact 1994; 49: 1593–4

    Google Scholar 

  3. 3.

    Verrept H. Marokkaaanse migranten en hun geneesmiddelen. Med Antropol 1992; 4: 184–98

    Google Scholar 

  4. 4.

    Verrept H, Schillemans L. Ziektegedrag van Marokkaaanse migranten met vakantie in Marokko. Ned Tijdschr Geneeskd 1994; 138: 337–9

    PubMed  CAS  Google Scholar 

  5. 5.

    Dandekar UP, Chandra RS, Dalvi SS, et al. Analysis of a clinically important interaction between phenytoin and Shankhapushpi, an Ayurvedic preparation. J Ethnopharmacol 1992; 35: 285–8

    PubMed  CAS  Article  Google Scholar 

  6. 6.

    Shima K, Tanaka A, Ikegami H, et al. Effect of dietary fiber, glucomannan, on absorption of sulfonylurea in man. Horm Metab Res 1983; 15: 1–3

    PubMed  CAS  Article  Google Scholar 

  7. 7.

    Huupponen R, Seppälä P, Iisalo E. Effect of guar gum, a fibre preparation, on digoxin and penicillin absorption in man. Eur J Clin Pharmacol 1984; 26: 279–81

    PubMed  CAS  Article  Google Scholar 

  8. 8.

    Gin H, Orgerie MB, Aubertin J. The influence of guar gum on absorption of metformin from the gut in healthy volunteers. Horm Metab Res 1989; 21: 81–3

    PubMed  CAS  Article  Google Scholar 

  9. 9.

    Jaeger A, George C, Lambert H, et al. Les accidents immunoallergiques au cours des traitements par un veinotrope contenant des catéchines. Trois observations. Thérapie 1980; 35: 733–41

    PubMed  CAS  Google Scholar 

  10. 10.

    Wälti M, Neftel KA, Jost R, et al. IgE- und IgG-Antikörpergegen Flavonoide nach Therapie mit flavonoidhaltigen Medikamenten. Schweiz Med Wochenschr 1986; 116: 98–103

    PubMed  Google Scholar 

  11. 11.

    Imbasciati E, De Cristofaro V, Scherini A, et al. Acute renal failure due to (+)-cyanidanol-3-induced hemolytic anemia. Nephron 1987; 46: 323

    PubMed  CAS  Article  Google Scholar 

  12. 12.

    Gandolfo GM, Girelli G, Conti L, et al. Hemolytic anemia and thrombocytopenia induced by cyanidanol. Acta Haematol 1992; 88: 96–9

    PubMed  CAS  Article  Google Scholar 

  13. 13.

    Lin JL, Ho YS. Flavonoid-induced acute nephropathy. Am J Kidney Dis 1994; 23: 433–40

    PubMed  CAS  Google Scholar 

  14. 14.

    Maechel H. Diarrhée chronique secondaire au Cirkan. Gastroenterol Clin Biol 1992; 16: 373

    PubMed  CAS  Google Scholar 

  15. 15.

    Thomas-Anterion C, Guy Cl, Vial F, et al. Diarrhées chroniques inexpliquées, à propos de quatre nouveaux cas sous Cyclo 3 fort® et revue de la littérature. Rev Med Interne 1993; 14: 215–7

    PubMed  CAS  Article  Google Scholar 

  16. 16.

    Beaugerie L, Luboinski J, Brousse N, et al. Drug induced lymphocytic colitis. Gut 1994; 35: 426–8

    PubMed  CAS  Article  Google Scholar 

  17. 17.

    Takegoshi K, Tohyama T, Okuda K, et al. A case of Venoplant-induced hepatic injury. Gastroenterol Jpn 1986; 21: 62–5

    PubMed  CAS  Google Scholar 

  18. 18.

    Jiménez Gómez R, Saldaña Garrido D, Martín Arias LH, et al. Somnolencia en el curso de un tratamiento con diosmina. Med Clin 1991; 97: 198–9

    Google Scholar 

  19. 19.

    Hausen BM, Bruhn G, Tilsley DA. Contact allergy to Australian blackwood (Acacia melanoxylon R.Br.): isolation and identification of new hydroxyflavan sensitizers. Contact Dermatitis 1990; 23: 33–9

    PubMed  CAS  Article  Google Scholar 

  20. 20.

    Geier J, Fuchs T, Wahl R. Anaphylaktischer Schock durch einen Mariendistel-Extrakt bei Soforttyp-Allergie auf Kiwi. Allergologie 1989; 13: 387–8

    Google Scholar 

  21. 21.

    Daniel PT, Holzschuh J, Berg PA. The pathogenesis of cianidanol-induced fever. Eur J Clin Pharmacol 1988; 34: 241–7

    PubMed  CAS  Article  Google Scholar 

  22. 22.

    Park BK, Pirmohamed M, Kitteringham NR. Idiosyncratic drug reactions: a mechanistic evaluation of risk factors. Br J Clin Pharmacol 1992; 34: 377–95

    PubMed  CAS  Article  Google Scholar 

  23. 23.

    Lacomblez L, Bensimon G, Isnard F, et al. Effect of yohimbine on blood pressure in patients with depression and orthostatic hypotension induced by clomimpramine. Clin Pharmacol Ther 1989; 45: 241–51

    PubMed  CAS  Article  Google Scholar 

  24. 24.

    Landis E, Shore E. Yohimbine-induced bronchospasm. Chest 1989; 96: 1424

    PubMed  CAS  Article  Google Scholar 

  25. 25.

    Sandler B, Aronson P. Yohimbine-induced cutaneous drug eruption, progressive renal failure, and lupus-like syndrome. Urology 1993; 41: 343–5

    PubMed  CAS  Article  Google Scholar 

  26. 26.

    Kommission E — Aufberereitungsmonographien. Dtsch Apoth Ztg 1993; 133: 2791–4

    Google Scholar 

  27. 27.

    De Smet PAGM. Drugs used in non-orthodox medicine. In: Dukes MNG, editor. Side effects of drugs. 12th ed. Amsterdam: Elsevier, 1992: 1209–32

    Google Scholar 

  28. 28.

    Shibata MA, Hirose M, Tanaka H, et al. Induction of renal cell tumors in rats and mice, and enhancement of hepatocellular tumor development in mice after long-term hydroquinone treatment. Jpn J Cancer Res 1991; 82: 1211–9

    PubMed  CAS  Article  Google Scholar 

  29. 29.

    Kari FW, Bucher J, Eustis SL, et al. Toxicity and carcinogenicity of hydroquinone in F344/N rats and B6C3F1 mice. Food Chem Toxicol 1992; 30: 737–47

    PubMed  CAS  Article  Google Scholar 

  30. 30.

    Frohne D. Untersuchungen zur Frage der harndesinfizierenden Wirkungen von Bärentraubenblatt-Extrakten. Planta Med 1970; 18: 1–25

    PubMed  CAS  Article  Google Scholar 

  31. 31.

    Divicenzo GD, Hamilton ML, Reynolds RC, et al. Metabolic fate and disposition of (14C)hydroquinone given orally to Sprague-Dawley rats. Toxicology 1984; 33: 9–18

    Article  Google Scholar 

  32. 32.

    Oso BA. Mushrooms and the Yoruba people of Nigeria. Mycologia 1975; 67: 311–9

    PubMed  CAS  Article  Google Scholar 

  33. 33.

    De Smet PAGM. Ethnopharmacological art in perspective: enema scenes in black African sculpture. Int Pharm J 1992; 6: 197–202, 239-44

    Google Scholar 

  34. 34.

    De Smet PAGM. An introduction to herbal pharmacoepidemiology. J Ethnopharmacol 1993; 38: 197–208

    PubMed  Article  Google Scholar 

  35. 35.

    De Smet PAGM, Vulto AG. Drugs used in non-orthodox medicine. In: Dukes MNG, editor. Side effects of drugs. Annual 11. Amsterdam: Elsevier, 1987: 422–31

    Google Scholar 

  36. 36.

    Onrot J, Goldberg MR, Biaggioni I, et al. Oral yohimbine in human autonomic failure. Neurol 1987; 37: 215–20

    CAS  Article  Google Scholar 

  37. 37.

    Price LH, Charney DS, Heninger GR. Three cases of manic symptoms following yohimbine administration. Am J Psychiatry 1984; 141: 1267–8

    PubMed  CAS  Google Scholar 

  38. 38.

    Ingram CG. Some pharmacologic actions of yohimbine and chlorpromazine in man. Clin Pharmacol Ther 1962; 3: 345–52

    Google Scholar 

  39. 39.

    Carbo M, Segura J, De la Torre R, et al. Effect of quinolones on caffeine disposition. Clin Pharmacol Ther 1989; 45: 234–40

    PubMed  CAS  Article  Google Scholar 

  40. 40.

    Harder S, Fuhr U, Staib AH, et al. Ciprofloxacin-caffeine: a drug interaction established using in vivo and in vitro investigations. Am J Med 1989; 87: 89S–91S

    PubMed  CAS  Article  Google Scholar 

  41. 41.

    Healy DP, Polk RE, Kanawati L, et al. Interaction between oral ciprofloxacin and caffeine in normal volunteers. Antimicrob Agents Chemother 1989; 33: 474–8

    PubMed  CAS  Article  Google Scholar 

  42. 42.

    Mahr G, Soergel F, Granneman GR, et al. Effects of temafloxacin and ciprofloxacin on the pharmacokinetics of caffeine. Clin Pharmacokinet 1992; 22Suppl. 1: 90–7

    PubMed  CAS  Article  Google Scholar 

  43. 43.

    Schellens JH, Ghabrial H, van der Wart HH, et al. Differential effects of quinidine on the disposition of nifedipine, sparteine, and mephenytoin in humans. Clin Pharmacol Ther 1991; 50: 520–8

    PubMed  CAS  Article  Google Scholar 

  44. 44.

    Gram LF, Debruyne D, Caillard V, et al. Substantial rise in sparteine metabolic ratio during haloperidol treatment. Br J Clin Pharmacol 1989; 27: 272–5

    PubMed  CAS  Article  Google Scholar 

  45. 45.

    Gram LF, Brosen K, Danish University Antidepressant Group. Moclobemide treatment causes a substantial rise in the sparteine metabolic ratio. Br J Clin Pharmacol 1993; 35: 649–52

    PubMed  CAS  Article  Google Scholar 

  46. 46.

    Galloway JH, Farmer K, Weeks GR, et al. Potentially hazardous compound in a herbal slimming remedy. Lancet 1992; 340: 179

    PubMed  CAS  Article  Google Scholar 

  47. 47.

    Atal CK, Zutshi U, Bedi KL, et al. Scientific evidence on the role of Ayurvedic herbals on bioavailability of drugs. J Ethnopharmacol 1981; 4: 229–32

    PubMed  CAS  Article  Google Scholar 

  48. 48.

    Bano G, Raina RK, Zutshi U, et al. Effect of piperine on bioavailability and pharmacokinetics of propranolol and theophylline in healthy volunteers. Eur J Clin Pharmacol 1991; 41: 615–7

    PubMed  CAS  Article  Google Scholar 

  49. 49.

    Atal CK, Dubey RK, Singh J. Biochemical basis of enhanced drug bioavailability by piperine: evidence that piperine is a potent inhibitor of drug metabolism. J Pharmacol Exp Ther 1985; 232: 258–62

    PubMed  CAS  Google Scholar 

  50. 50.

    Bhat BG, Chandrasekhara N. Interaction of piperine with rat liver microsomes. Toxicology 1987; 44: 91–8

    PubMed  CAS  Article  Google Scholar 

  51. 51.

    Bano G, Amla V, Raina RK, et al. The effect of piperine on pharmacokinetics of phenytoin in healthy volunteers. Planta Med 1987; 53: 568–9

    PubMed  CAS  Article  Google Scholar 

  52. 52.

    Bailey DG, Arnold JMO, Spence JD. Grapefruit juice and drugs: how significant is the interaction? Clin Pharmacokinet 1994; 26: 91–8

    PubMed  CAS  Article  Google Scholar 

  53. 53.

    De Smet PAGM, Smeets OSNM. Potential risks of health food products containing yohimbe extracts. BMJ 1994; 309: 958

    PubMed  Article  Google Scholar 

  54. 54.

    Vanherweghem JL, Depierreux M, Tielemans C, et al. Rapidly progressive interstitial renal fibrosis in young women: association with slimming regimen including Chinese herbs. Lancet 1993; 341: 387–91

    PubMed  CAS  Article  Google Scholar 

  55. 55.

    Vanhaelen M, Vanhaelen-Fastre R, But P, et al. Identification of aristolochic acid in Chinese herbs. Lancet 1994; 343: 174

    PubMed  CAS  Article  Google Scholar 

  56. 56.

    Quansheng C. Mutong. In: Chang H-M, But PP-H, editors. Pharmacology and applications of Chinese materia medica. Vol 1. Singapore: World Scientific Publishing, 1986: 195–8

    Google Scholar 

  57. 57.

    De Smet PAGM. Aristolochia species. In: De Smet PAGM, Keller K, Hänsel R, et al., editors. Adverse effects of herbal drugs. Vol 1. Heidelberg: Springer-Verlag, 1992: 79–89

    Chapter  Google Scholar 

  58. 58.

    But PP. Herbal poisoning caused by adulterants or erroneous substitutes. J R Trop Med Hyg 1994; 97: 371–4

    CAS  Google Scholar 

  59. 59.

    De Smet PAGM, Elferink F, Verpoorte R. Linksdraaiend tetrahydropalmatine in Chinese tablet. Ned T Geneesk 1989; 133: 308

    PubMed  Google Scholar 

  60. 60.

    Quansheng C. Yanhusuo. In: Chang H-M, But PP-H, editors. Pharmacology and applications of Chinese materia medica. Vol 1. Singapore: World Scientific Publishing, 1986: 515–24

    Google Scholar 

  61. 61.

    Horowitz RS, Gomez H, Moore LL, et al. Jin Bu Huan toxicity in children — Colorado 1993. MMWR 1993; 42: 633–6

    Google Scholar 

  62. 62.

    Woolf GM, Petrovic LM, Rojter SE, et al. Acute hepatitis associated with the Chinese herbal product Jin Bu Huan. Ann Intern Med 1994; 121: 729–35

    PubMed  CAS  Google Scholar 

  63. 63.

    De Smet PAGM. Scutellaria species. In: De Smet PAGM, Keller K, Hänsel R, et al., editors. Adverse effects of herbal drugs. Vol 2. Heidelberg: Springer-Verlag, 1993: 289–96, 317

    Chapter  Google Scholar 

  64. 64.

    De Smet PAGM. Toxicological outlook on the quality assurance of herbal remedies. In: De Smet PAGM, Keller K, Hänsel R, et al., editors. Adverse effects of herbal drugs. Vol 1. Heidelberg: Springer-Verlag, 1992: 1–72

    Chapter  Google Scholar 

  65. 65.

    De Smet PAGM, Elferink F. Te veel lood in Chinese kruidenpillen. Pharm Weekbl 1990; 125: 169

    Google Scholar 

  66. 66.

    McElvaine MD, Harder EM, Johnson L, et al. Lead poisoning from the use of Indian folk medicines. JAMA 1990; 264: 2212–3

    PubMed  CAS  Article  Google Scholar 

  67. 67.

    Mitchell-Heggs CAW, Conway M, Cassar J. Herbal medicine as a cause of combined lead and arsenic poisoning. Hum Exp Toxicol 1990; 9: 195–6

    PubMed  CAS  Article  Google Scholar 

  68. 68.

    Dolan G, Jones AP, Blumsohn A, et al. Lead poisoning due to Asian ethnic treatment for impotence. J R Soc Med 1991; 84: 630–1

    PubMed  CAS  Google Scholar 

  69. 69.

    Goldman JA, Myerson G. Chinese herbal medicine: camouflaged prescription antiinflammatory drugs, corticosteroids, and lead. Arthritis Rheum 1991; 34: 1207

    PubMed  CAS  Article  Google Scholar 

  70. 70.

    Saryan LA. Surreptitious lead exposure from an Asian Indian medication. J Anal Toxicol 1991; 15: 336–8

    PubMed  CAS  Google Scholar 

  71. 71.

    Smitherman J, Harber P. A case of mistaken identity: herbal medicine as a cause of lead toxicity. Am J Ind Med 1991; 20: 795–8

    PubMed  CAS  Article  Google Scholar 

  72. 72.

    Dunbabin DW, Tallis GA, Popplewell PY, et al. Lead poisoning from Indian herbal medicine (Ayurveda). Med J Aust 1992; 157: 835–6

    PubMed  CAS  Google Scholar 

  73. 73.

    Kang-Yum E, Oransky SH. Chinese patent medicine as a potential source of mercury poisoning. Vet Hum Toxicol 1992; 34: 235–8

    PubMed  CAS  Google Scholar 

  74. 74.

    Schaumburg HH, Berger A. Alopecia and sensory polyneuropathy from thallium in a Chinese herbal medication. JAMA 1992; 268: 3430–1

    PubMed  CAS  Article  Google Scholar 

  75. 75.

    Kew J, Morris C, Aihie A, et al. Arsenic and mercury intoxication due to Indian ethnic remedies. BMJ 1993; 306: 506–7

    PubMed  CAS  Article  Google Scholar 

  76. 76.

    Keen RW, Deacon AC, Delves HT, et al. Indian herbal remedies for diabetes as a cause of lead poisoning. Postgrad Med J 1994; 70: 113–4

    PubMed  CAS  Article  Google Scholar 

  77. 77.

    Markowitz SB, Nunez CM, Klitzman S, et al. Lead poisoning due to Hai Ge Fen. The porphyrin content of individual erythrocytes. JAMA 1994; 271: 932–4

    PubMed  CAS  Article  Google Scholar 

  78. 78.

    Perharic L, Shaw D, Colbridge M, et al. Toxicological problems resulting from exposure to traditional remedies and food supplements. Drug Saf 1994; 11: 284–94

    PubMed  CAS  Article  Google Scholar 

  79. 79.

    Sheerin NS, Monk PN, Aslam M, et al. Simultaneous exposure to lead, arsenic and mercury from Indian ethnic remedies. Br J Clin Pract 1994; 48: 332–3

    PubMed  CAS  Google Scholar 

  80. 80.

    De Smet PAGM, Elferink F, Kerremans ALM, et al. Dexamethason in oosterse Cow’s Head Brand Tung Shueh pillen. Pharm Weekbl 1990; 125: 414–5

    Google Scholar 

  81. 81.

    DuPont RL, Bogema SC. Benzodiazepines in a health-catalog product. JAMA 1990; 264: 695

    PubMed  CAS  Article  Google Scholar 

  82. 82.

    Barnes AR, Paul CJ, Secrett PC. Adulteration of an Asian alternative medicine. Pharm J 1991; 247: 650

    Google Scholar 

  83. 83.

    Floren AE, Fitter W. Contamination of urine with diazepam and mefenamic acid from an Oriental remedy. J Occup Med 1991; 33: 1168–9

    PubMed  CAS  Article  Google Scholar 

  84. 84.

    Joseph AM, Biggs T, Garr M, et al. Stealth steroids. N Engl J Med 1991; 324: 62

    PubMed  CAS  Google Scholar 

  85. 85.

    Karunanithy R, Sumita KP. Undeclared drugs in traditional Chinese antirheumatoid medicine. Int J Pharm Pract 1991; 1: 117–9

    Article  Google Scholar 

  86. 86.

    Segasothy M, Samad S. Illicit herbal preparation containing phenylbutazone causing analgesic nephropathy. Nephron 1991; 59: 166–7

    PubMed  CAS  Article  Google Scholar 

  87. 87.

    Diamond JR, Pallone TL. Acute interstitial nephritis following use of Tung Shueh pills. Am J Kidney Dis 1994; 24: 219–21

    PubMed  CAS  Google Scholar 

  88. 88.

    De Smet PAGM, Smeets OSNM. Dexamethason in Oosterse ‘Gentian Rheumatism’ capsules. Pharm Weekbl 1994; 129: 30

    Google Scholar 

  89. 89.

    Graham-Brown RAC, Bourke JF, Bumphrey G. Chinese herbal remedies may contain steroids. BMJ 1994; 308: 473

    PubMed  CAS  Article  Google Scholar 

  90. 90.

    Hughes JR, Higgins EM, Pembroke AC. Oral dexamethasone masquerading as a Chinese herbal remedy. Br J Dermatol 1994; 130: 261

    PubMed  CAS  Article  Google Scholar 

  91. 91.

    Van der Stricht BI, Parvais OE, Vanhaelen-Fastré RJ, et al. Remedies may contain cocktail of active drugs. BMJ 1994; 308: 1162

    Article  Google Scholar 

  92. 92.

    Abt AB, Oh JY, Huntington RA, et al. Chinese herbal medicine induced acute renal failure. Arch Int Med 1995; 155: 211–2

    CAS  Article  Google Scholar 

  93. 93.

    Osol A, Farrar GE. The Dispensatory of the United States of America. 25th ed. Philadelphia: J.B. iLippincott Company, 1955

    Google Scholar 

  94. 94.

    Lewin L. Gifte und Vergiftungen. Lehrbuch der Toxikologie. Fünfte unveränderte Ausgabe. Ulm/Donau: Karl F. Haug Verlag, 1962

    Google Scholar 

  95. 95.

    Kingsbury JM. Poisonous plants of the United States and Canada. Englewood Cliffs: Prentice-Hall Inc, 1964

    Google Scholar 

  96. 96.

    Gessner O, Orzechowski G. Gift- und Arzneipflanzen von Mitteleuropa. 3. Auflage. Heidelberg: Carl Winter Universitäts-verlag, 1974

    Google Scholar 

  97. 97.

    Madaus G. Lehrbuch der biologischen Heilmittel. Band I–III. Hildesheim: Georg Olms Verlag, 1979

    Google Scholar 

  98. 98.

    Mitchell J, Rook A. Botanical dermatology. Plants and plant products injurious to the skin. Vancouver: Greengrass, 1979

    Google Scholar 

  99. 99.

    Moeschlin S. Klinik und Therapie der Vergiftungen. 7. Auflage. Stuttgart: Georg Thieme Verlag, 1986

    Google Scholar 

  100. 100.

    Chang H-M, But PP-H, editors. Pharmacology and applications of Chinese materia medica. Vol 1. Singapore: World Scientific Publishing, 1986

    Google Scholar 

  101. 101.

    Chang H-M, But PP-H, editors. Pharmacology and applications of Chinese materia medica. Vol 2. Singapore: World Scientific Publishing, 1987

    Google Scholar 

  102. 102.

    Frohne D, Pfänder HJ. Giftpflanzen. 3rd ed. Stuttgart: Wissenschaftliche Verlagsgesellschaft, 1987

    Google Scholar 

  103. 103.

    Der Marderosian A, Liberti LE. Natural product medicine. A scientific guide to foods, drugs, cosmetics. Philadelphia: George F. Stickley Company, 1988

    Google Scholar 

  104. 104.

    De Smet PAGM, Keller K, Hänsel R, et al. Adverse effects of herbal drugs. Vol 1. Heidelberg: Springer-Verlag, 1992

    Book  Google Scholar 

  105. 105.

    Hänsel R, Keller K, Rimpler H, et al. Hagers Handbuch der Pharmazeutischen Praxis. 5th ed. Vierter Band: Drogen A–D. Berlin: Springer-Verlag, 1992

    Google Scholar 

  106. 106.

    Stricker BHCh, De Smet PAGM. Individual agents: herbal and other non-orthodox agents. In: Stricker BHCh, editor. Drug-induced hepatic injury. 2nd ed. Amsterdam: Elsevier Science Publishers, 1992: 525–38

    Google Scholar 

  107. 107.

    Tang W, Eisenbrand G. Chinese drugs of plant origin. Chemistry, pharmacology, and use in traditional and modern medicine. Heidelberg: Springer-Verlag, 1992

    Google Scholar 

  108. 108.

    De Smet PAGM, Keller K, Hänsel R, et al. Adverse effects of herbal drugs. Vol 2. Heidelberg: Springer-Verlag, 1993

    Book  Google Scholar 

  109. 109.

    Hänsel R, Keller K, Rimpler H, et al. Hagers Handbuch der Pharmazeutischen Praxis. 5th ed. Fünfter Band: Drogen E–O. Berlin: Springer-Verlag, 1993

    Google Scholar 

  110. 110.

    Tyler VE. The new honest herbal. A sensible guide to the use of herbs and related remedies. 3rd ed. Binghamton: Pharmaceutical Products Press, 1993

    Google Scholar 

  111. 111.

    Bisset NG, Wichtl M, editors. Herbal drugs and phytopharmaceuticals. A handbook for practice on a scientific basis. Stuttgart: Medpharm Scientific Publishers, 1994

    Google Scholar 

  112. 112.

    Hänsel R, Keller K, Rimpler H, et al. Hagers Handbuch der Pharmazeutischen Praxis. 5th ed. Fünfter Band: Drogen P-Z. Berlin: Springer-Verlag, 1994

    Google Scholar 

  113. 113.

    Roth L, Daunderer M, Kormann K. Giftpflanzen — Pflanzengifte: Wirkung, Vorkommen, Wirkung, Therapie; allergische und phototoxische Reaktionen. 4. Auflage, Landsberg: Ecomed, 1994

    Google Scholar 

  114. 114.

    Teuscher E, Lindequist U. Biogene Gifte. Biologie — Chemie-Pharmakologie. 2. Auflage. Stuttgart: Gustav Fischer, 1994

    Google Scholar 

  115. 115.

    De Smet PAGM, D’Arcy PF. Drug interactions with herbal and other non-orthodox drugs. In: D’ Arcy PF, McElnay JC, Welling PG, editors. Mechanisms of drug interactions. Heidelberg: Springer Verlag. In press

  116. 116.

    De Smet PAGM, Keller K, Hänsel R, et al. Adverse effects of herbal drugs. Vol 3. Heidelberg: Springer-Verlag. In press

  117. 117.

    Kao W-F, Hung D-Z, Lin K-P, et al. Podophyllotoxin intoxication: toxic effect of Bajiaolian in herbal therapeutics. Hum Exp Toxicol 1992; 11: 480–7

    PubMed  CAS  Article  Google Scholar 

  118. 118.

    Deji D, Qingtian Z. Shancigu. In: Chang H-M, But PP-H, editors. Pharmacology and applications of Chinese materia medica. Vol 1. Singapore: World Scientific Publishing Co, 1986: 117–23

    Google Scholar 

  119. 119.

    Songbai Y. Zangqie. In: Chang H-M, But PP-H, editors. Pharmacology and applications of Chinese materia medica. Vol 2. Singapore: World Scientific Publishing Co, 1987: 1250–5

    Google Scholar 

  120. 120.

    Arzneimittelkommission der Deutschen Apotheker. Chinesisches Pflanzenpulver. Dtsch Apoth Ztg 1994; 134: 2212

    Google Scholar 

  121. 121.

    Pourrat J, Montastruc JL, Lacombe JL, et al. Néphropathie associée des herbes chinoises 2 cas. Presse Med 1994; 23: 1669

    PubMed  CAS  Google Scholar 

  122. 122.

    Auriche M, Loupi E. Does proof of causality ever exist in pharmacovigilance? Drug Saf 1993; 9: 230–5

    PubMed  CAS  Article  Google Scholar 

  123. 123.

    De Smet PAGM. Should herbal medicine-like products be licensed as medicines. Special licensing seems the best way forward. BMJ 1995; 310: 1023–4

    PubMed  Article  Google Scholar 

  124. 124.

    Herbert V, Drivas G. Spirulina and vitamin B12. JAMA 1982; 248: 3096–7

    PubMed  CAS  Article  Google Scholar 

  125. 125.

    Herbert V. The 1986 Herman Award Lecture. Nutrition science as a continually unfolding story: the folate and vitamin B12 paradigm. Am J Clin Nutr 1987; 46: 387–402

    PubMed  CAS  Google Scholar 

  126. 126.

    Van den Berg H, Dagnelie PC, Van Staveren WA. Vitamin B12 and seaweed. Lancet 1988; 1: 242–3

    PubMed  Article  Google Scholar 

  127. 127.

    Dagnelie PC, Van Staveren WA, Van den Berg H. Vitamin B12 from algae appears not to be bioavailable. Am J Clin Nutr 1991; 53: 695–7, 988

    PubMed  CAS  Google Scholar 

  128. 128.

    Atherton DJ. Towards the safer use of traditional remedies. Greater awareness of toxicity is needed. BMJ 1994; 308: 673–4

    PubMed  CAS  Article  Google Scholar 

  129. 129.

    Smith T, editor. The British Medical Association family doctor — home adviser. The first practical guide to understanding your symptoms and recognising medical emergencies. 2nd ed. London: Dorling Kindersley, 1992: 154–5

    Google Scholar 

  130. 130.

    Castot A, Larrey D. Hépatites observées au cours d’un traitement par un médicament ou une tisane contenant de la germandrée petit-chêne. Bilan des 26 cas rapportés aux Centres Régionaux de Pharmacovigilance. Gastroenterol Clin Biol 1992; 16: 916–22

    PubMed  CAS  Google Scholar 

  131. 131.

    Siegers C-P, Von Hertzberg-Lottin E, Otte M, et al. Anthranoid laxative abuse — a risk for colorectal cancer? Gut 1993; 34: 1099–101

    PubMed  CAS  Article  Google Scholar 

  132. 132.

    De Smet PAGM, Vulto AG. Drugs used in non-orthodox medicine. In: Dukes MNG, Beeley L, editors. Side effects of drugs. Annual 12. Amsterdam: Elsevier, 1988: 402–15

    Google Scholar 

  133. 133.

    Westendorf J, Marquardt H, Poginsky B, et al. Genotoxicity of naturally occurring hydroxyanthraquinones. Mutat Res 1990; 240: 1–12

    PubMed  CAS  Article  Google Scholar 

  134. 134.

    Siegers C-P. Anthranoid laxatives and colorectal cancer. Trends Pharmacol Sci 1992; 13: 229–31

    PubMed  CAS  Article  Google Scholar 

  135. 135.

    Mori H, Sugie S, Niwa K, et al. Induction of intestinal tumours in rats given chrysazin. Br J Cancer 1985; 52: 781–3

    PubMed  CAS  Article  Google Scholar 

  136. 136.

    Mori H, Sugie S, Niwa K, et al. Carcinogenicity of chrysazin in large intestine and liver of mice. Jpn J Cancer Res 1986; 77: 871–6

    PubMed  CAS  Google Scholar 

  137. 137.

    Mori H, Yoshimi N, Iwata H, et al. Carcinogenicity of naturally occurring 1-hydroxyanthraquinone in rats: induction of large bowel, liver and stomach neoplasms. Carcinogenesis 1990; 11: 799–802

    PubMed  CAS  Article  Google Scholar 

Download references

Author information

Affiliations

Authors

Corresponding author

Correspondence to Peter A. G. M. De Smet.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

De Smet, P.A.G.M. Health Risks of Herbal Remedies. Drug-Safety 13, 81–93 (1995). https://doi.org/10.2165/00002018-199513020-00003

Download citation